Bayer Pharma AG

Allemagne

 
Quantité totale PI 1 057
Quantité totale incluant filiales 1 466 (+ 409 pour les filiales)
Rang # Quantité totale PI 1 264
Note d'activité PI 3,2/5.0    297
Rang # Activité PI 2 403
Parent Bayer AG
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

265 0
117 0
670 1
4
 
Dernier brevet 2025 - Gadolinium chelate compounds for...
Premier brevet 1993 - Dihydrospirorenone as an antiand...
Dernière marque 2007 - FEM JENAPHARM
Première marque 1997 - ENDOMETRION

Filiales

1 subsidiaries with IP (408 patents, 1 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Gadolinium chelate compounds for use in magnetic resonance imaging. An aqueous pharmaceutical co...
Invention Active metabolites of kinesin spindle protein inhibitor conjugates. The present invention relate...
Invention Treatment of cardiopulmonary disorders. The present invention relates to the use of (5S)-{[2-(4-...
Invention Compounds, compositions and methods for cancer patient stratification and cancer treatment. The ...
Invention Cytostatic conjugates with integrin ligands. The present invention relates to novel pharmaceutic...
Invention Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-...
Invention Substituted indazoles, methods for the production thereof, pharmaceutical preparations that conta...
Invention Formulation of contrast media and process of preparation thereof. The present disclosure relates...
2023 Invention 6-phenyl-4,5-dihydropyridazin-3(2h)-one derivatives as pde3a and pde3b inhibitors for treating ca...
Invention Treatment of cardiopulmonary disorders. The present invention relates to the use of (5S)-{[2-(4-c...
Invention Process for preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphe...
Invention 2-methyl-quinazolines. The present invention describes 2-methyl-quinazoline compounds of general...
Invention Specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodies. The inve...
Invention Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors. The present invention covers com...
Invention Combinations of copanlisib with anti-pd-1 antibody. * combinations of: compon...
Invention N-[2-({4-[3-(anilino)-4-oxo-4,5,6,7-tetrahydro-1h-pyrrolo[3,2-c]pyridin-2-yl]pyridin-3-yl)oxy)eth...
Invention 2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of dhodh. The present invention prov...
Invention Masp inhibitory compounds and uses thereof. The present invention relates to novel Mannose-bindi...
Invention Carboxylic acid aromatic amides as antagonists of bradykinin b1 receptor. The present invention r...
Invention Antibody drug conjugates (adcs) having enzymatically cleavable groups. The invention relates to ...
Invention Prodrugs of cytotoxic active agents having enzymatically cleavable groups. The invention relates...
2022 Invention Pharmaceutical dry powder inhalation formulation
Invention Pharmaceutical dry powder inhalation formulation. The present invention relates to pharmaceutical...
Invention Substituted aminoquinolones as dgkalpha inhibitors for immune activation. The present invention c...
Invention New gadolinium chelate compounds for use in magnetic resonance imaging. An aqueous pharmaceutica...
Invention Substituted macrocyclic indole derivatives. The present invention relates to substituted macrocyc...
Invention 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer. The present ...
Invention Dihydrooxadiazinones. The present invention provides dihydrooxydiazinone compounds of general for...
Invention Crystalline forms of 3-(5-methyl-1,3-thiazol-2-yl)-5-[(3r)-tetrahydrofuran-3-yloxy]-n-{(1r)-1-[2-...
2021 Invention Substituted 6-(1h-pyrazol-1-yl)pyrimidin-4-amine derivatives and uses thereof. The present inven...
Invention Substituted oxopyridine derivatives. The invention relates to substituted oxopyridine derivative...
Invention Carboxylic acid aromatic amides. The present invention relates to carboxylic acid aromatic amides...
Invention Antibody drug conjugates with enzymatically cleavable groups. The present invention relates to no...
Invention Substituted aminothiazoles as dgkzeta inhibitors for immune activation. The present invention co...
Invention P450 bm3 monooxygenase variants for c19-hydroxylation of steroids. The present invention relates...
2020 Invention Process for preparing (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naph...
Invention [1,2,4]triazolo[1,5-c]quinazolin-5-amines. The present invention covers [1,2,4]triazolo[1,5-c]qu...
Invention Analogues of 3-(5-methyl-1,3-thiazol-2-yl)-n-{(1r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}be...
2018 Invention 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer. The present...
2017 Invention Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-l,4-dihydro-...
2007 P/S Chemicals used in industry, science and photography. Soaps; perfumery, essential oils, cosmetics,...
P/S Pharmaceutical preparations. Surgical and medical instruments and devices, medicinal catheters.
2006 P/S Chemicals used in industry, science and photography. Pharmaceutical products and health-care prod...
1997 P/S Pharmaceutical and sanitary preparations.
P/S Medicines for humans and animals.